Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention.
作者信息
Khan Safi U, Riaz Irbaz Bin, Rahman Hammad, Lone Ahmed N, Raza Munis, Khan Muhammad Shahzeb, Riaz Anum, Kaluski Edo
机构信息
1 Department of Medicine, West Virginia University, USA.
2 Mayo Clinic, USA.
出版信息
Eur J Prev Cardiol. 2019 Mar;26(4):429-432. doi: 10.1177/2047487318795245. Epub 2018 Aug 28.
Abstract
摘要
相似文献
1
Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention.经皮冠状动脉介入治疗后急性冠状动脉综合征患者双联抗血小板治疗持续时间的Meta分析。
Eur J Prev Cardiol. 2019 Mar;26(4):429-432. doi: 10.1177/2047487318795245. Epub 2018 Aug 28.
2
Comprehensive Outcomes Evaluation After Percutaneous Coronary Intervention in Stable Ischemic Heart Disease and Acute Coronary Syndrome for Short- Versus Standard-Term Dual Antiplatelet Therapy: A Systematic Review and Meta-analysis of Randomized Control Trials.经皮冠状动脉介入治疗稳定型缺血性心脏病和急性冠状动脉综合征短期与标准双联抗血小板治疗的综合结局评估：随机对照试验的系统评价和荟萃分析。
J Cardiovasc Pharmacol. 2020 Nov;76(5):574-583. doi: 10.1097/FJC.0000000000000902.
3
Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.经皮冠状动脉介入治疗患者基于血小板功能检测的个体化双联抗血小板治疗：随机对照试验的荟萃分析
BMC Cardiovasc Disord. 2017 Jun 15;17(1):157. doi: 10.1186/s12872-017-0582-6.
4
Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).随机双抗血小板治疗（DAPT）研究中停用噻吩吡啶类药物治疗后的心肌梗死风险
Circulation. 2017 May 2;135(18):1720-1732. doi: 10.1161/CIRCULATIONAHA.116.024835. Epub 2017 Feb 22.
5
Should all stent patients have prolonged dual antiplatelet therapy?所有支架植入患者都应该接受延长的双联抗血小板治疗吗？
JACC Cardiovasc Interv. 2015 May;8(6):873-875. doi: 10.1016/j.jcin.2015.04.001.
6
Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.急性冠状动脉综合征或经皮冠状动脉介入治疗后房颤患者的双联与三联抗栓治疗：一项更新的荟萃分析
Cardiovasc Revasc Med. 2020 Feb;21(2):239-241. doi: 10.1016/j.carrev.2019.08.015. Epub 2019 Aug 20.
7
Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.双重剂量与标准剂量氯吡格雷在经皮冠状动脉介入治疗的急性冠状动脉综合征患者中的应用：吸烟状态的影响。
J Am Heart Assoc. 2017 Nov 3;6(11):e006577. doi: 10.1161/JAHA.117.006577.
8
Focus on pharma in acute coronary syndrome.关注急性冠状动脉综合征中的药物治疗。
Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):1-2. doi: 10.1093/ehjcvp/pvz074.
9
The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement.药物洗脱支架置入术后双联抗血小板治疗的疗程历程
Arch Cardiovasc Dis. 2015 Oct;108(10):469-71. doi: 10.1016/j.acvd.2015.09.001. Epub 2015 Oct 1.
10
Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome.急性冠脉综合征经皮冠状动脉介入治疗后双联抗血小板治疗的最佳持续时间。
Trends Cardiovasc Med. 2020 May;30(4):198-202. doi: 10.1016/j.tcm.2019.05.008. Epub 2019 May 31.
引用本文的文献
1
Antiplatelet Therapy with Integrated Traditional Chinese and Western Medicine for Use in Myocardial Ischemia-Reperfusion Injury: A Review of Clinical Applications and Mechanisms.中西医结合抗血小板治疗在心肌缺血再灌注损伤中的应用：临床应用与机制综述
Evid Based Complement Alternat Med. 2021 Jul 20;2021:7409094. doi: 10.1155/2021/7409094. eCollection 2021.
2
Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis.低剂量利伐沙班治疗冠心病患者的疗效和安全性：系统评价和荟萃分析。
J Thromb Thrombolysis. 2020 Nov;50(4):913-920. doi: 10.1007/s11239-020-02114-7.
本文引用的文献
1
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.急性冠状动脉综合征患者经皮冠状动脉介入治疗后 6 个月与 12 个月或更长时间双联抗血小板治疗（SMART-DATE）：一项随机、开放标签、非劣效性试验。
Lancet. 2018 Mar 31;391(10127):1274-1284. doi: 10.1016/S0140-6736(18)30493-8. Epub 2018 Mar 12.
2
Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention.冠状动脉疾病：更积极二级预防的风险分层与患者选择
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):88-100. doi: 10.1177/2047487317706586.
3
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.缺血性心脏病二级预防中的抗血小板和抗血栓治疗。
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):61-70. doi: 10.1177/2047487317707854.
4
Cardiac rehabilitation programme as a non-pharmacological platelet inhibitory tool in acute coronary syndrome survivors.心脏康复计划作为急性冠脉综合征幸存者的非药物性血小板抑制手段。
Eur J Prev Cardiol. 2017 Jul;24(11):1148-1156. doi: 10.1177/2047487317704937. Epub 2017 Apr 25.
5
6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.长期依维莫司洗脱支架置入后 6 个月与 12 个月双联抗血小板治疗：血管内超声-XPL 随机临床试验。
JACC Cardiovasc Interv. 2016 Jul 25;9(14):1438-46. doi: 10.1016/j.jcin.2016.04.036. Epub 2016 May 17.
6
Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial.生物可降解聚合物西罗莫司洗脱支架植入术后6个月与12个月双重抗血小板治疗的比较：I-LOVE-IT 2试验的随机子研究
Circ Cardiovasc Interv. 2016 Feb;9(2):e003145. doi: 10.1161/CIRCINTERVENTIONS.115.003145.
7
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.ISAR-SAFE 研究：药物洗脱支架置入后氯吡格雷治疗 6 个月与 12 个月的随机、双盲、安慰剂对照临床试验
Eur Heart J. 2015 May 21;36(20):1252-63. doi: 10.1093/eurheartj/ehu523. Epub 2015 Jan 23.
8
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.载有佐他莫司的药物洗脱支架置入后双联抗血小板治疗 3 个月与 12 个月：OPTIMIZE 随机试验。
JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183.
9
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).一种新的双联抗血小板治疗停药策略：RESET 试验（ Endeavor 佐他莫司洗脱支架置入后 3 个月双联抗血小板治疗的真实安全性和疗效）。
J Am Coll Cardiol. 2012 Oct 9;60(15):1340-8. doi: 10.1016/j.jacc.2012.06.043. Epub 2012 Sep 19.
10
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial.冠状动脉支架置入术后双联抗血小板治疗的短期与长期疗程：一项随机多中心试验。
Circulation. 2012 Apr 24;125(16):2015-26. doi: 10.1161/CIRCULATIONAHA.111.071589. Epub 2012 Mar 21.
Zotero 插件